Loading
Massachusetts General Hospital surgical oncologist and 2026-2027 President of the Society of Surgical Oncology, with expertise in liver cancer and melanoma.
Kenneth Tanabe is President of the Society of Surgical Oncology for 2026-2027 and Chief of Surgical Oncology at Massachusetts General Hospital, where he is a professor of surgery at Harvard Medical School. His clinical and research work focuses on hepatobiliary malignancies and melanoma, including hepatocellular carcinoma biology and oncolytic virus therapy. He has held numerous leadership roles in US surgical oncology.
Shares Society of Surgical Oncology and the tags leadership, clinician-scientist, surgical oncology.
Shares Hepatocellular carcinoma and the tags leadership, clinician-scientist, surgical oncology, liver cancer.
Shares Annals of surgical oncology and the tags leadership, clinician-scientist.
Shares Annals of surgical oncology and the tags leadership, clinician-scientist, surgical oncology.
Shares Annals of surgical oncology and the tags leadership, clinician-scientist.
Shares Hepatocellular carcinoma and the tags leadership, clinician-scientist, liver cancer.
Shares Annals of surgical oncology and the tags leadership, clinician-scientist.
Shares Annals of surgical oncology and the tag leadership.